Andrea Gutschmidt

Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis.

Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis.

Journal: Scientific reports

Published: February 07, 2025

Exogenous binding immunoglobulin protein (BiP) enhance immune regulatory phenotype in ex-vivo Mtb infected PBMCs stratified based on QuantiFERON response.

Exogenous binding immunoglobulin protein (BiP) enhance immune regulatory phenotype in ex-vivo Mtb infected PBMCs stratified based on QuantiFERON response.

Journal: Cytokine

Published: October 23, 2024

Protocol to phenotype and quantify mycobacteria-specific myeloid cells from human airways by mass cytometry.

Protocol to phenotype and quantify mycobacteria-specific myeloid cells from human airways by mass cytometry.

Journal: STAR protocols

Published: July 17, 2024

Investigating Mycobacterium tuberculosis sufR (rv1460) in vitro and ex vivo expression and immunogenicity.

Investigating Mycobacterium tuberculosis sufR (rv1460) in vitro and ex vivo expression and immunogenicity.

Journal: PloS one

Published: February 17, 2023

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients.

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients.

Journal: Frontiers in immunology

Published: February 25, 2022

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

Journal: The Lancet. Infectious diseases

Published: July 06, 2021

Immunoglobulin profile and B-cell frequencies are altered with changes in the cellular microenvironment independent of the stimulation conditions.

Immunoglobulin profile and B-cell frequencies are altered with changes in the cellular microenvironment independent of the stimulation conditions.

Journal: Immunity, inflammation and disease

Published: February 19, 2020

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: June 06, 2019

Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.

Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.

Journal: The Journal of infection

Published: March 19, 2019

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.

Journal: Clinical and vaccine immunology : CVI

Published: September 07, 2016

Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.

Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.

Journal: European journal of immunology

Published: August 08, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026